Financials, Healthcare Oct 08, 2021 08:44 PM (GMT+8) · EqualOcean
Financial Associated Press, Oct. 8 - BGI announced that the thalassemia gene detection kit (joint probe anchored polymerization sequencing method) of European medicine, a wholly-owned subsidiary of the company, was recently approved to be listed by Saudi Food & Drug Authority (SFDA).
Related companies: